A newly discovered link between pancreatic cancer and neural signaling reveals a promising drug target that slows tumor ...

Researchers at the Johns Hopkins Kimmel Cancer Center have discovered how certain pathogenic bacteria in gut and breast ...

Optune Pax® with the chemotherapy combination of gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancer.

The latest research published in Genes & Diseases unveils groundbreaking insights into the role of the aging process and the associated factor EMP1 in the progression of resectable pancreatic cancer ...

Breast cancer is one of the most common cancers among American women. It is estimated that within the United States, about 300,000 new cases will be diagnosed in 2025. The average risk of a woman ...

Neutrophils are everywhere in the bloodstream and are built for speed, rushing to sites of injury or infection to contain ...

The scientist is author of one of the most influential works in the history of tumor research ...

Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs, MDSCs, and Tregs-orchestrate a tumor-permissive microenvironment.

An oral combination treatment may prevent the progression of advanced leiomyosarcoma, one of the most common subtypes of soft ...